Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/asj/sjaf008 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reevaluating Semaglutide in Post-Bariatric Contouring Surgery: The Role of Undermined Immune Response and Nutritional Deficiency in Wound Complications.
Aesthet Surg J
January 2025
Regenerative Medicine Institute (REMEDI) at CÚRAM SFI Research Centre for Medical Devices, School of Medicine, College of Medicine, Nursing and Health Sciences, University of Galway, Galway City, Galway County, Ireland.
Consensus on Current Landscape and Treatment Trends of Obesity in India for Primary Care Physicians.
J Assoc Physicians India
October 2023
Associate Professor, Department of Endocrinology, MS Ramaiah Medical College, Bengaluru, Karnataka, India.
: The objective of this consensus article was to form a list of expert recommendations and an easily adaptable algorithm for obesity management in India by primary care physicians (PCPs). : A Delphi-based model was followed to form a list of the consensus recommendations. Consensus statements were created from the results of a literature review that were graded as per the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) criteria.
View Article and Find Full Text PDFThe Impact Once-Weekly Semaglutide 2.4 mg Will Have on Clinical Practice: A Focus on the STEP Trials.
Nutrients
May 2022
Diabetes Complications Research Centre, Conway Institute, University College Dublin, D04 V1W8 Dublin, Ireland.
Obesity is a complex and chronic disease that raises the risk of various complications. Substantial reduction in body weight improves these risk factors. Lifestyle changes, including physical activity, reduced caloric ingestion, and behavioral therapy, have been the principal pillars in the management of obesity.
View Article and Find Full Text PDFBackground: Randomized clinical trials with the aim of evaluating the cardiovascular risks associated with glucagon-like peptide 1 (GLP-1) receptor agonists, lixisenatide, liraglutide, semaglutide, and exenatide, have been conducted. They showed different results among the agents, but the reason has not been explained.
Objective: To evaluate the cardiovascular risks associated with GLP-1 receptor agonists by using an alternative measure to the hazard ratio.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!